Clinical Trials Logo

Cancer Survivor clinical trials

View clinical trials related to Cancer Survivor.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04215029 Active, not recruiting - Cancer Survivor Clinical Trials

Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

This trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic partners. A lifestyle intervention may help researchers learn if social support can help African American prostate cancer patients and their partners improve their quality of life, support from their partner, physical activity, diet, and inflammation.

NCT ID: NCT03860961 Active, not recruiting - Clinical trials for Prostate Adenocarcinoma

Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

Start date: August 2, 2019
Phase: N/A
Study type: Interventional

This trial studies how well increasing the dose of survivorship care planning improves care and outcomes in prostate cancer survivors receiving radiation therapy and androgen deprivation therapy. There is a need for coordinated care between the cancer care team with the primary care team. This is especially important for prostate cancer survivors who need routine cancer care follow-up with their radiation oncologist and also coordinated routine follow-up with their primary care provider (PCP). This is important because androgen deprivation therapy increases a patient's risk for developing diabetes, hypercholesterolemia, and cardiovascular events. Increasing the dose of survivorship may improve care and outcomes of cancer survivors than standard practices.

NCT ID: NCT03612531 Active, not recruiting - Dysphagia Clinical Trials

Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

MANTLE
Start date: August 6, 2018
Phase: N/A
Study type: Interventional

This trial studies how well manual therapy works in treating fibrosis-related late effect dysphagia in head and neck cancer survivors. Manual therapy is the use of massage and stretching exercises to increase blood flow and muscle movement in the neck, throat, jaw, and mouth, which may help to improve swallowing ability and range of motion in participants who have had treatment for head and neck cancer.

NCT ID: NCT03035500 Active, not recruiting - Prostate Carcinoma Clinical Trials

Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

Start date: July 23, 2008
Phase: N/A
Study type: Interventional

This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.

NCT ID: NCT03025139 Active, not recruiting - Clinical trials for Stage IIIA Breast Cancer

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)

PTW
Start date: February 20, 2017
Phase: N/A
Study type: Interventional

This randomized phase III trial studies how well mindfulness meditation or survivorship education work in improving behavioral symptoms in younger stage 0-III breast cancer survivors. Behavioral interventions, such as mindfulness meditation, use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Survivorship education after treatment may reduce stress and improve the well-being and quality of life of patients with breast cancer. Mindfulness meditation or survivorship education may help improve the health behaviors of younger breast cancer survivors.

NCT ID: NCT02194387 Active, not recruiting - Overweight Clinical Trials

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Start date: September 17, 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies different types of energy balance interventions to see how well they work in increasing the physical activity levels of breast cancer gene-positive patients, Lynch syndrome-positive patients, chronic lymphocytic leukemia (CLL) survivors or family members of cancer survivors who are at high risk for cancer. Increasing exercise and eating healthy foods may help reduce the risk of cancer. Studying how well different types of interventions work in motivating cancer survivors or high-risk family members to increase exercise and healthy food choices may help doctors plan the most effective motivational program for cancer prevention.

NCT ID: NCT01824745 Active, not recruiting - Breast Cancer Clinical Trials

Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors

Start date: July 15, 2013
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies survivorship care planning in improving the quality of life in breast cancer survivors. Survivorship care planning may reduce stress and improve the well-being and quality of life of cancer survivors.

NCT ID: NCT01347970 Active, not recruiting - Cancer Survivor Clinical Trials

Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial

Start date: May 2012
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies the side effects and how well low-dose carvedilol works in preventing congestive heart failure (CHF) in younger cancer survivors exposed to high dose anthracyclines for management of childhood cancer. Carvedilol may help lower the risk of cardiovascular complications